More on RYTM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $87.66 |
|
|||
| Open | $87.66 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $87.66 | ||||
| Day Low | $87.66 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 216 | ||||
- Rhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by Citizens
- Form DEFA14A RHYTHM PHARMACEUTICALS,
- Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
- Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics
- Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
- Form 4 RHYTHM PHARMACEUTICALS, For: May 18 Filed by: Smith Hunter C
- Form 4 RHYTHM PHARMACEUTICALS, For: May 15 Filed by: German Christopher Paul
- Form SCHEDULE 13G/A RHYTHM PHARMACEUTICALS, Filed by: PERCEPTIVE ADVISORS LLC
- Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
- Rhythm Pharmaceuticals (RYTM) PT Raised to $143 at Canaccord
Entities mentioned with RYTM
- FDA | View Related Stories »
- PDUFA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- Needham & Company | View Related Stories »
- Show More...
